Authors


Cheryl Krader

Latest:

IL-17 potential therapeutic target for pustular psoriasis

Researchers performed a systematic review of available reports on the therapeutic benefit of interleukin (IL)-17/T-helper 17 (Th17) axis inhibitors in patients with generalized pustular psoriasis (GPP). Read what they discovered in this article.


Art Papier, M.D., FAAD

Latest:

AI: It’s not dermatologist vs. machine

In this month's Innovation article, Steve Xu, M.D., FAAD, highlights a company and innovator who are using artificial intelligence to augment physician decision-making, not replace it. ƒ


Mildred López Piñeiro, M.D.

Latest:

Ultrasound technology may be useful treatment for rosacea

Drs. López and Kaufman discuss two new studies that examine the use of ultrasound technology as a new modality for treatment of erythematotelangiectatic and refractory rosacea.


Morgan Petronelli

Latest:

Clinical Pearls for Superficial and Medium Depth Chemical Peels

Harold J. Brody, MD, provides his best tips and tricks for superficial and medium depth chemical peels in a presentation at the 2022 ASDS Annual Meeting.


Usama Syed

Latest:

DTC compounded medications: A treatment option for a system in need?

How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.


Raymond Miller, J.D.

Latest:

DTC compounded medications: A treatment option for a system in need?

How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.


Brandon Kirsch, M.D., J.D.

Latest:

DTC compounded medications: A treatment option for a system in need?

How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.


Hans Hofland, Ph.D.

Latest:

Spotlight on Dermira and the QBREXZA story

Hans Hofland, Ph.D, and Dr. Steve Xu shine a spotlight on Dermira and its novel topical medicine indicated for primary axillary hyperhidrosis in patients 9 years of age and older.


Todd Petersen

Latest:

A successful ownership transition

Todd Petersen, CEO of VitalSkin Dermatology, discusses the last part of your transition journey – ensuring a smooth, successful transition for you, your team and your patients.


Carol Soutor, M.D.

Latest:

Mind-body therapies effective for skin disorders

Carol Soutor, M.D., writes about efficacy and safety of mind-body therapies for the treatment of various skin conditions. 



Brian Kim, M.D., MTR

Latest:

Advances in Itch: Brian S. Kim, MD, Shares Insights and Treatment Tips

Kim, who received the Marion B. Sulzberger Award at the 2024 American Academy of Dermatology Annual Meeting, discussed itch research an implications for clinical practice.


Duke Leahey

Latest:

Nuogen Pharma: Innovation in the fight against itch

Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.


Bobby Buka, M.D., J.D.

Latest:

Practicing dermatology in the time of COVID-19

Read one New York physician's insights on practice survival and patient care during the pandemic.


Denise Myshko

Latest:

CVS Removes Biosimilars From Drug List

One notable change: CVS Caremark has removed the Humira biosimilar Amjevita and now prefers Hyrimoz and an unbranded biosimilar.



Patricia Richey, MD, FAAD

Latest:

The Role of Laser Treatments in Preventing Skin Cancer

Patricia Richey, MD, delves into efficacy of the 1927 and 1550 nanometer lasers to prevent skin cancers.


Karishma Daftary, BA

Latest:

Think Globally to Combat Acne

Take a world tour of the global game-changing advances and home-grown success strategies dermatologists in the United States and abroad are using to tackle the challenges of acne.


Rocco Serrao, MD, FAAD

Latest:

Navigating Vitiligo Treatment: Decoding Pigmentation & Accessing Care

Rocco Serrao, MD, FAAD, addresses potential barriers to access and affordability of narrowband UVB phototherapy and topical medications for vitiligo treatment, while highlighting available resources to assist patients in overcoming these obstacles.


Lauren Joszt

Latest:

Atopic Dermatitis Remains Controlled Even After Reduction of Dupilumab Dose

Patients with persistently controlled atopic dermatitis who had their doses reduced were able to maintain their low disease activity.


Mona Shahriari, MD, FAAD

Latest:

Game-Changing Insights on Itch, Psoriatic Disease, and Innovations With Mona Shahriari, MD, FAAD

Shahriari highlighted advanced dermatology treatments, clinical trial inclusivity, and key care strategies for complex skin conditions at Fall Clinical 2024.



Suneel Chilukuri, M.D.

Latest:

Latest Laser and Skincare Innovations for Hyperpigmentation with Suneel Chilukuri, MD, FAAD, FACMS

Chilukuri shared that 2 new sunscreen ingredients, physalis angulata and pycnogenol, can prevent heat-induced pigmentation, offering new options for patients.


Mike Hennessy Sr, Founder and Chairman, MJH Life Sciences

Latest:

Saving the World Through Pharmaceutical Innovation

The COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.


Doris Day, MD, FAAD

Latest:

Doris Day, MD, Discusses Primary Axillary Hyperhidrosis and Brella SweatControl Patch

Brella received FDA clearance last week for improving excessive underarm sweating.


Kavita Mariwalla, MD, FAAD

Latest:

Navigating Skin Aging Across Diverse Tones: Tailored Approaches and Cultural Awareness

An expert in dermatology discusses the intricacies of addressing anti-aging concerns in patients with diverse skin tones, emphasizing the importance of tailoring management to meet their unique needs, understanding the underlying mechanisms of aging, and appreciating the cultural nuances within patient populations.


Jason M. O'Dell, MS, CWM

Latest:

Offering an Insurance Package to Retain and Reward Employees: What Dermatologists Should Know

Explore various elements that can go into a comprehensive insurance benefits package for dermatology practice employees.



Paul Scott Premo

Latest:

CBP/β-catenin Antagonists: A Safe and Novel Approach for Skin Rejuvenation and Aging

Take a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.


David M. Pariser, MD, FACP, FAAD

Latest:

Improving Hyperhidrosis Treatment: The Role of IHhS

David M. Pariser, MD, FACP, FAAD, secretary and a founding board member of the International Hyperhidrosis Society, discussed the latest in hyperhidrosis research and the organization’s commitment to helping clinicians treat the condition.

© 2024 MJH Life Sciences

All rights reserved.